Navigation Links
Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation
Date:5/12/2008

in the solicitation of proxies from Iomai's stockholders with respect to the proposed transaction. Information regarding Iomai's executive officers and directors, and their beneficial ownership of Iomai's common stock as of March 26, 2008 is available in Iomai's proxy statement for its 2008 Annual Meeting of Stockholders, which was filed with the SEC on April 4, 2008. Other information regarding the interests of such potential participants in the proxy solicitation will be contained in the proxy statement and other relevant materials to be filed with the SEC when they become available.

Forward Looking Statements for Intercell AG:

This communication expressly or implicitly contains certain advance statements concerning Intercell AG and its business. Such statements involve certain known and unknown risks, uncertainties and other factors which could cause the actual results, financial condition, performance or achievements of Intercell AG to be materially different from any future results, performance or achievements expressed or implied by such advance statements. Intercell AG is providing this communication as of this date and does not update any advance statements contained herein as a result of new information, future events or otherwise.

Forward Looking Statements for Iomai Corporation:

Some matters discussed in this press release constitute "forward-looking statements" that involve known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied by the forward-looking statements. Such forward-looking statements include statements about the anticipated acquisition of Iomai by Intercell and timing of and potential benefits of the anticipated acquisition; the potential synergies between the combination of Iomai and Intercell's product technologies; expectations regarding the timing of clinical trials and product development; the ability of Iomai's adjuvant patches to provide p
'/>"/>

SOURCE Iomai Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
2. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
3. Image Solutions, Inc. Acquires Zurich Biostatistics, Inc.
4. New Data Show Doripenem as Effective as Commonly Used Therapies in Treating Hospital-Acquired Pneumonias
5. U.S. Preventive Medicine Acquires Specialty Disease Management
6. MacroChem Acquires Rights to Pexiganan, a Novel Topical Anti-Infective for Treatment of Diabetic Foot Infections, From Genaera
7. FDA Accepts Wyeths Supplemental New Drug Application for Tygacil for the Treatment of Patients with Community-Acquired Pneumonia
8. Nastech Reacquires Teriparatide (Parathyroid Hormone; PTH1-34) Nasal Spray from Procter & Gamble
9. Prescient Medical, Inc. Acquires New Technology to Detect Inflammation in Coronary Blood Vessels
10. Enanta Reports New Macrolide-Related Drug Class, Bicyclolides, to Combat Hospital and Community Acquired Superbug Infections, Including MRSA
11. Iomai Trial Shows 100 Percent Immune Response in Elderly Subjects Vaccinated With Novel Travelers Diarrhea Patch Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... 2014  Diplomat, the nation,s largest independent specialty ... winners in the 2014 Innovations in Specialty Pharmacy ... results of the competition were announced in the ... Diplomat was honored as a Top ... program. Through Diplomat University, the company has implemented ...
(Date:8/22/2014)... 22, 2014  Dr. Mark Rasak , MD ... Lifetime Achievement Award in the field of Medicine as ... Clinical Associates. Dr. Rasak has over 15 ... aspects of the business; overseeing the daily operations; interventional ... intervention. In addition, he is an honored Fellow of ...
(Date:8/22/2014)... , Aug. 22, 2014 Research ... "Global and Chinese Particulate Respirators Industry Report 2014" ... Global and Chinese Particulate Respirators Industry Report 2014 is ... of the global particulate respirators industry with a focus ... basic overview of the industry including definitions, classifications, applications ...
Breaking Medicine Technology:Diplomat honored as a Top Innovator by Specialty Pharmacy News 2Dr. Mark Rasak, MD is recognized by Continental Who's Who with the Diamond Lifetime Achievement Award 2Global and Chinese Particulate Respirators Industry Report 2014 2
... FALLS CHURCH, Va., May 19, 2011 MinuteClinic, the ... CVS ), and Inova Health System, a leading ... million patients a year, have entered into a clinical ... care services they provide in communities throughout Arlington, Fairfax, ...
... Ampio Pharmaceuticals, Inc. (Nasdaq Capital Market: AMPE) ("Ampio" ... for previously approved drugs and new molecular entities ("NMEs"), ... on the NASDAQ Capital Market under the ticker symbol ... Wingerter, the Company,s CEO, said, "We are extremely excited ...
Cached Medicine Technology:MinuteClinic Forms Strategic Affiliation With Inova Health System in Northern Virginia 2MinuteClinic Forms Strategic Affiliation With Inova Health System in Northern Virginia 3MinuteClinic Forms Strategic Affiliation With Inova Health System in Northern Virginia 4Ampio Pharmaceuticals, Inc. to Begin Trading on the NASDAQ Capital Market 2
(Date:8/22/2014)... 2014 Mi40x , the latest guide ... show people how they can use a simple 4-minute trick ... matter of weeks has caught the attention of Shane Michaels, ... of the most well-known bodybuilders in the industry, and if ... today, that in itself is a testament to how effective ...
(Date:8/22/2014)... Paying tuition and other related educational expenses ... for four nurse educators pursuing advanced degrees, thanks to ... Foundation for Nursing Education . This year’s recipients – ... than in 2013, thanks to these named NLN Foundation ... Marcil Endowment Funds, both donated by Kathy Mershon; the ...
(Date:8/22/2014)... 2014 Mueller Sports Medicine is excited ... exciting new product that provides non-drug instant relief for ... while you heal. The package includes 7 days of ... technology – it is not kinesiology tape. It’s made ... System for Plantar Fasciitis is a breakthrough in ...
(Date:8/22/2014)... West Orange, NJ. August 22, 2014. A ... shows that persons with multiple sclerosis (MS) may ... cognitive rehabilitation. The study was epublished ahead of ... (Yael Goverover, Helen Genova, Hali Griswold, Nancy D. ... awareness in persons with multiple sclerosis doi: 10.3233/NRE-141113). ...
(Date:8/22/2014)... Menstrual leaks risk stains and embarrassment, ... decided that there needed to be a better way ... producible in design variations, the Safety Net optimizes protection ... avoids embarrassment and promotes peace of mind. The pad ... The original design was submitted to the Fort Lauderdale ...
Breaking Medicine News(10 mins):Health News:Mi40x: Review Exposes Ben Pakulski’s Guide to Packing on Lean Muscle Fast 2Health News:NLN Foundation for Nursing Education Announces 2014 Faculty Scholarship Awards 2Health News:NLN Foundation for Nursing Education Announces 2014 Faculty Scholarship Awards 3Health News:Mueller Introduces FasciaDerm® PFTape™ System for Plantar Fasciitis 2Health News:Kessler Foundation study of self-awareness in MS has implications for rehabilitation 2
... have developed a Vitamin D pill that could give a ... of prostrate cancer when given along with chemotherapy drugs. ... lived for an average of an extra nine months longer ... edition of BBC News. ,The pill delivers ...
... transplantation—including the psychological and ethical aspects// of the controversial ... of England now endorses moving cautiously forward in performing ... the Jan. 27 issue of Transplantation. ,In ... that facial transplantation should not be attempted until further ...
... new study by researchers at the Harvard School of ... United States //has resulted in a net savings of ... benefits associated with avoided fear and suffering. This first ... vaccination appears as part of a special issue on ...
... gamblers in Britain. A study reveals// that Englishmen prefer to ... fruits. ,On an average, ?800 per year ... Online gambling has also increased the number of gamblers over ... (BMA) has expressed its apprehensions and fears about teenagers getting ...
... pressure in the arteries. High blood pressure (hypertension) //is often ... for years without knowing it. ,A person is ... is around 120/80. Canadians regard blood pressure with systolic reading ... and 89 as high-normal blood pressure. ,Approx. 2.5 ...
... Hospitals, one of the largest eye care hospital networks in ... seven more in the offing. ,The Chennai facility ... prominent ophthalmic surgeon and managing director of Prems' Eye Clinic. ... ,The Vasan Eye Care Group has earmarked a Rs.450 million ...
Cached Medicine News:Health News:Royal College Issues Revised Guidelines for Face Transplantation 2Health News:Royal College Issues Revised Guidelines for Face Transplantation 3Health News:Billions of Dollars Saved in U.S. By Polio Vaccination 2Health News:Slightly High Blood Pressure is Also Hazardous 2
... combination of the Aliquoting System RSD 800A ... ACM-8). This turns out in an efficient ... laboratory. The System automates all important front-end ... via cap identification, sample quality control, decapping, ...
... The Aliquoting System RSD 800A is an ... and archiving (additional tube type identification via ... to process various sample tubes in a ... sorting areas are customized and offer high ...
... Sorting System RS 800 can sort different ... manual sorting are not necessary anymore and ... in a very timesaving and economical way ... Optionally a Tube Type Identification via Cap ...
... MGB Alert Detection Reagents provide molecular labs ... based assays. By using our MGB technology, ... Nanogen is now able to provide molecular ... acid sequences of specific organisms or genetic ...
Medicine Products: